Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Action of Alefacept in Psoriasis
NCT00150982Phase 2Completed
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Sep 2003
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of alefacept in psoriasis, sponsored by University of Medicine and Dentistry of New Jersey. Started Sep 2003; status: completed.
02
Drugs
alefacept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00150982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150982.